Position in DNLI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$496,730
New position
Shares Held
19,313
first reported quarter
Ownership
0.012%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#148
of 290 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALLSTATE CORP holds $63,475,982 across 75 Biotechnology names. DNLI ranks #33 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
22,006 | $10,931,039 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,878 | $4,288,708 | |
| 3 | RPRX |
Royalty Pharma plc
|
58,143 | $3,260,078 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
16,120 | $3,018,953 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,185 | $2,463,930 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
63,116 | $2,233,675 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
45,639 | $2,146,858 | |
| 8 | MRNA |
Moderna, Inc.
|
29,980 | $2,099,499 |
All Filings in DNLI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $496,730 | 19,313 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||